Clinical trials
Completed Hodgkin Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2003 | 4 |
| 2004 | 1 |
| 2005 | 3 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 10 |
| Fondazione Italiana Linfomi - ETS | 8 |
| Bristol-Myers Squibb | 3 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Novartis Pharmaceuticals | 3 |
| Seagen Inc. | 2 |
| A.O.U. Città della Salute e della Scienza | 1 |
| ADC Therapeutics S.A. | 1 |
| Advice Pharma Group srl | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 51 |
| Lymphoma, Non-Hodgkin | 20 |
| Multiple Myeloma | 17 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 16 |
| Leukemia, Myeloid, Acute | 14 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
| Lymphoma, Large B-Cell, Diffuse | 12 |
| Lymphoma, Mantle-Cell | 12 |
| Lymphoma | 11 |
| Lymphoma, Follicular | 11 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.